Skip to main content
Canna~Fangled Abstracts

The cannabinoid acids, analogs and endogenous counterparts.

By April 1, 2014No Comments
 2014 Apr 1. pii: S0968-0896(14)00223-5. doi: 10.1016/j.bmc.2014.03.038. [Epub ahead of print]

pm8The cannabinoid acids, analogs and endogenous counterparts.

Abstract

The cannabinoid acids are a structurally heterogeneous group of compounds some of which are endogenous molecules and others that are metabolites of phytocannabinoids. The prototypic endogenous substance is N-arachidonoyl glycine (NAgly) that is closely related in structure to the cannabinoid agonist anandamide. The most studied phytocannabinoid is Δ9-THC-11-oic acid, the principal metabolite of Δ9-THC. Both types of acids have in common several biological actions such as low affinity for CB1 anti-inflammatory activity and analgesic properties. This suggests that there may be similarities in their mechanism of action, a point that is discussed in this review. Also presented are reports on analogs of the acids that provide opportunities for the development of novel therapeutic agents, such as ajulemic acid.
Copyright © 2014 Elsevier Ltd. All rights reserved.

KEYWORDS:

Ajulemic acid, Cannabinoid, Lipoamino acid, Lipoxin, NAgly, Prostaglandin, Δ(9)-THC-11-oic acid

PMID:

 24731541
[PubMed – as supplied by publisher]

LinkOut – more resources

Full Text Sources

  • Icon for Elsevier Science

Graphical abstract

Full-size image (23 K)

Abbreviations

  • NAglyN-arachidonoyl glycine;
  • AJAajulemic acid;
  • THCtetrahydrocannabinol;
  • CBDcannabidiol;
  • CBNcannabinol

 
 
 

Other Literature Sources

potp font 1